Product Images Nikki

The given text appears to be a list of studies that have reported hazard ratios, rate ratios, and odds ratios for different medical conditions. The list also mentions the type of studies conducted, such as prospective cohort studies, retrospective cohort studies, and case-control studies. There is no further context available to provide a more specific description.*

This text shows different ranges of blood clot incidents in women based on their condition. The ranges vary depending on whether the woman is pregnant or not, and if they use Contraceptive Oral Contraceptives (COC) or not. The number of women with a blood clot out of 10,000 Women Years is also provided. The data for pregnancy is based on the duration of pregnancy in reference studies, with a model assumption that the duration of pregnancy is nine months.*

Drospirenone Ethinyl estradiol is a combination of two female hormones that prevent ovulation. It is used as a contraceptive to prevent pregnancy.*

This is a chart showing different types of birth control methods and their effectiveness rates. It states that there are fewer than 1 pregnancy per 100 pregnancies in women who use certain types of birth control methods, including implants, injections, intrauterine devices and sterilization. Birth control pills and the skin patch are also listed. Other methods, such as condoms, diaphragm, no sex during fertile days, spermicide and withdrawal are listed, but with lower effectiveness rates. The chart shows that not using any birth control method is the least effective at preventing pregnancy.*

This is a description of a medication called "drospirenone and ethinyl estradiol tablets USP" manufactured by LUPIN. It comes in a dose of 3mg/0.02mg and is taken orally. There is a calendar provided that shows the appropriate start date for the medication. There is also information on how to store the medication, with the recommended temperature range of 15 to 30 degrees Celsius.*

This is a chart that provides ranges for the number of women, out of 10,000 women years, who experience blood clots at different stages. The ranges vary depending on whether the woman is a non-COC user, a COC user, pregnant, or postpartum (12 weeks only). The chart provides a range of 108-3109 for non-pregnant non-COC users and a range of 5-20 for pregnant women. For postpartum women, the range is 40-65. The chart is based on a model assumption that pregnancy lasts nine months.*

The text seems to be a product label for a medication called Nikki, which is a combination of drospirenone and ethinyl estradiol tablets. The tablets have a strength of 3mg/0.02mg and are manufactured by Lupin Pharmaceuticals. The label includes a warning to keep the medication out of reach of children and contact information for the manufacturer. There is some indecipherable text and a pharmacy label is missing.*

This is a medication information sheet for a pink coated tablet named Nikki, which contains drospirenone and ethinyl estradiol. It is intended to be a contraceptive that prevents pregnancy but does not protect against HIV and other sexually transmitted diseases. The tablet comes in a 28 tablet wallet and should be kept out of children's reach. The text also mentions enhancing women's care and provides an NDC and Rx number. There is a lot number and a website provided for additional information.*

This is a package insert for Nikki contraceptive tablets containing information on the tablet dosage, drug indications, instructions on usage, and potential side effects.*